Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology-Reference-Cited by-同舟云学术

Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology

Published:2021-05 Issue:3 Volume:7 Page:644-652
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Palumbo Carlotta^ORCID,Pecoraro Angela,Knipper Sophie,Rosiello Giuseppe^ORCID,Luzzago Stefano,Deuker Marina^ORCID,Tian Zhe,Shariat Shahrokh F.,Simeone Claudio,Briganti Alberto,Saad Fred,Berruti Alfredo,Antonelli Alessandro,Karakiewicz Pierre I.

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Epidemiology of renal cell carcinoma;Capitanio;Eur Urol,2019

3. Rising incidence of renal cell cancer in the United States;Chow;JAMA,1999

4. Contemporary epidemiology of renal cell cancer;Chow;Cancer J,2008

5. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis;Sun;Eur Urol,2011

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of age, period, and cohort factors on the incidence of kidney cancer in Spain 1990-2019: Evidence from the global burden of disease study;Actas Urológicas Españolas (English Edition);2024-09

2. Efecto de la edad, el periodo y la cohorte en la incidencia del cáncer renal en España entre 1990 y 2019: datos del estudio Global Burden of Disease;Actas Urológicas Españolas;2024-09

3. Renal Cell Carcinoma;JAMA;2024-08-28

4. External validation of the ability of the mRENAL nephrometry score to identify patients at risk for major adverse events or local tumor recurrence after percutaneous renal cryoablation;Abdominal Radiology;2024-08-16

5. Avoiding “Needless” nephrectomy: What is the role of small renal mass biopsy in 2024?;Urologic Oncology: Seminars and Original Investigations;2024-08